A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Treatment of Malignancy Associated Weight Loss or Anorexia in Patients With NSCLC Interventions: Drug: Anamorelin Hydrochloride; Drug: Placebo Oral Tablet Sponsor: Helsinn Healthcare SA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anorexia | Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study | Weight Loss